Source:http://linkedlifedata.com/resource/pubmed/id/12612474
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2003-3-3
|
pubmed:abstractText |
Tc-tetrofosmin seems to show a prolonged thyroid retention when compared with Tc-sestamibi; this may explain its poorer performance in the dual-phase parathyroid scintigraphy. In order to verify objectively whether and to what extent Tc-sestamibi and Tc-tetrofosmin uptake and retention differ in the thyroid gland, we performed a head-to-head comparison between the tracers in 86 euthyroid subjects enrolled in five centres. Data were compared with those of Tc-pertechnetate obtained from the same subjects. For comparison purposes, quantitative data from the salivary glands were also obtained. Tc-sestamibi showed a higher early thyroid uptake (2.26+/-0.52 vs. 2.01+/-0.49, respectively; P<0.002) and a lower retention (1.4+/-0.37 vs. 1.65+/-0.58, respectively; P<0.002) when compared with Tc-tetrofosmin. This finding provides an objective basis for the poorer results of Tc-tetrofosmin in dual-phase parathyroid scintigraphy. Delayed Tc-tetrofosmin salivary gland uptake was unexpectedly high and approached the Tc-pertechnetate value (2.29+/-0.56 vs. 2.46+/-0.75, respectively; P =not significant). This finding should be kept in mind in order to avoid interpretation pitfalls in thyroid and parathyroid imaging with Tc-tetrofosmin, as well as in other oncological imaging of the neck region. This study definitely establishes that Tc-tetrofosmin and Tc-sestamibi are not twin but rather sibling tracers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Organophosphorus Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Organotechnetium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Pertechnetate Tc 99m,
http://linkedlifedata.com/resource/pubmed/chemical/Technetium Tc 99m Sestamibi,
http://linkedlifedata.com/resource/pubmed/chemical/technetium Tc 99m...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0143-3636
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12612474-Biological Transport,
pubmed-meshheading:12612474-Humans,
pubmed-meshheading:12612474-Hyperparathyroidism,
pubmed-meshheading:12612474-Italy,
pubmed-meshheading:12612474-Organophosphorus Compounds,
pubmed-meshheading:12612474-Organotechnetium Compounds,
pubmed-meshheading:12612474-Radiopharmaceuticals,
pubmed-meshheading:12612474-Reproducibility of Results,
pubmed-meshheading:12612474-Salivary Glands,
pubmed-meshheading:12612474-Sodium Pertechnetate Tc 99m,
pubmed-meshheading:12612474-Technetium Tc 99m Sestamibi,
pubmed-meshheading:12612474-Thyroid Gland,
pubmed-meshheading:12612474-Tissue Distribution
|
pubmed:year |
2003
|
pubmed:articleTitle |
Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
|
pubmed:affiliation |
Departments of Nuclear Medicine, Policlinico Gemelli, Università Cattolica del S Cuore, Rome, Italy. a.giordano@rm.unicatt.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|